HEPATO CARCINOMA

Clinical trials for HEPATO CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HEPATO CARCINOMA trials appear

Sign up with your email to follow new studies for HEPATO CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a diabetes drug help fight liver cancer? early safety trial completed

Disease control Completed

This early study tested whether a 3-week course of sitagliptin, a diabetes drug, is safe for people with liver cancer (HCC) who are having part of their liver removed. Only 14 patients took part. The goal was to see if the drug could help the immune system attack the tumor by pro…

Matched conditions: HEPATO CARCINOMA

Phase: PHASE1 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control

Last updated Jun 16, 2026 12:52 UTC

HEPATO CARCINOMA

Get alerted when new HEPATO CARCINOMA trials appear

Can a diabetes drug help fight liver cancer? early safety trial completed